D.E. Shaw & Co’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

D.E. Shaw & Co’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,347,844	Closed	-$3.34M	–	4624
2023 Q2	$3.34M	Hold	1,347,844	–	–	﹤0.01%	2204
2023 Q1	$1.97M	Buy	1,347,844 +100,000	+8%	+$186K	﹤0.01%	2709
2022 Q4	$2.42M	Buy	1,247,844 +468,626	+60%	+$513K	﹤0.01%	2783
2022 Q3	$304K	Buy	779,218 +536,300	+221%	+$285K	﹤0.01%	4292
2022 Q2	$146K	Buy	+242,918	New	+$127K	﹤0.01%	4651

D.E. Shaw & Co's ROIVW Position: Q3 2023 in Review

D.E. Shaw & Co sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 1,347,844 shares — an estimated $3.34M sold.

D.E. Shaw & Co first reported a position in ROIVW in Q2 2022 and held it in 5 quarters. The position peaked at $3.34M in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

D.E. Shaw & Co reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
D.E. Shaw & Co sold 1,347,844 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $3.34M.
D.E. Shaw & Co first reported a position in Roivant Sciences Ltd. Warrant in Q2 2022 and held it in 5 quarters.
D.E. Shaw & Co's Roivant Sciences Ltd. Warrant position peaked at $3.34M in Q2 2023.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.